S&P 500 Futures
(0.15%) 5 139.25 points
Dow Jones Futures
(0.10%) 38 480 points
Nasdaq Futures
(0.24%) 17 888 points
Oil
(-0.27%) $83.62
Gas
(1.72%) $1.956
Gold
(0.13%) $2 350.30
Silver
(0.64%) $27.71
Platinum
(1.57%) $936.60
USD/EUR
(-0.17%) $0.933
USD/NOK
(-0.31%) $10.99
USD/GBP
(-0.32%) $0.798
USD/RUB
(1.11%) $92.89

实时更新: CARGO Therapeutics, Inc. [CRGX]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间27 Apr 2024 @ 04:00

2.19% $ 18.68

购买 107425 min ago

@ $21.56

发出时间: 15 Feb 2024 @ 03:23


回报率: -13.34%


上一信号: Feb 14 - 22:30


上一信号: 出售


回报率: -1.98 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies...

Stats
今日成交量 89 542.00
平均成交量 313 909
市值 735.41M
EPS $0 ( 2024-03-27 )
下一个收益日期 ( $-1.050 ) 2024-06-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0.0400 (0.21%)
Insider Trading
Date Person Action Amount type
2024-01-12 Rtw Investments, Lp Sell 1 842 499 Common stock, par value $0.001 per share ("Common Stock")
2023-11-14 Rtw Investments, Lp Buy 0 Common stock, par value $0.001 per share
2023-11-14 Perceptive Advisors Llc Buy 333 333 Common Stock
2023-11-14 Perceptive Advisors Llc Buy 2 579 502 Common Stock
2023-11-14 Perceptive Advisors Llc Buy 333 333 Common Stock
INSIDER POWER
-17.45
Last 10 transactions
Buy: 3 296 168 | Sell: 4 503 291

音量 相关性

長: -0.27 (neutral)
短: 0.64 (weak)
Signal:(60.425) Neutral

CARGO Therapeutics, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

CARGO Therapeutics, Inc. 相关性 - 货币/商品

The country flag -0.24
( neutral )
The country flag -0.61
( weak negative )
The country flag 0.00
( neutral )
The country flag 0.34
( neutral )
The country flag 0.46
( neutral )
The country flag 0.69
( moderate )

CARGO Therapeutics, Inc. 财务报表

Annual 2022
营收: $0
毛利润: $0 (0.00 %)
EPS: $0
FY 2022
营收: $0
毛利润: $0 (0.00 %)
EPS: $0

Financial Reports:

No articles found.

CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。